Compare NNNN & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | DOLE |
|---|---|---|
| Founded | 2021 | 1851 |
| Country | Germany | Ireland |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | 2021 |
| Metric | NNNN | DOLE |
|---|---|---|
| Price | $25.50 | $14.72 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 12.8K | ★ 650.1K |
| Earning Date | 04-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $9,172,907,000.00 |
| Revenue This Year | N/A | $4.93 |
| Revenue Next Year | N/A | $1.72 |
| P/E Ratio | $446.57 | ★ $27.83 |
| Revenue Growth | N/A | ★ 8.23 |
| 52 Week Low | $7.03 | $12.52 |
| 52 Week High | $55.65 | $16.51 |
| Indicator | NNNN | DOLE |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 44.73 |
| Support Level | $26.31 | $14.53 |
| Resistance Level | $30.21 | $15.02 |
| Average True Range (ATR) | 2.10 | 0.31 |
| MACD | -0.28 | -0.03 |
| Stochastic Oscillator | 20.78 | 25.64 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace. Geographically, the company operates in United States, Ireland, U.K. Spain, Sweden, and Others.